SAN DIEGO--(BUSINESS WIRE)--May 17, 2018--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:

Steven Pacelli, Executive Vice President, Strategy and Corporate Development, and Matthew Dolan, Vice President Corporate Development, will present on behalf of the company at the William Blair 38 th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June 12, 2018 at 7:30am (CDT). The presentation, which will occur live at the Four Seasons Hotel, will be concurrently webcast.

The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180517005314/en/

CONTACT: DexCom, Inc.

Steven R. Pacelli, 858-200-0200

Executive Vice President, Strategy and Corporate Development

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA ILLINOIS

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES OTHER HEALTH COMMUNICATIONS PUBLIC RELATIONS/INVESTOR RELATIONS GENERAL HEALTH

SOURCE: DexCom, Inc.

Copyright Business Wire 2018.

PUB: 05/17/2018 08:00 AM/DISC: 05/17/2018 08:01 AM

http://www.businesswire.com/news/home/20180517005314/en